ACLCX | VIVAX | ACLCX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 32 years | - |
Gain YTD | -0.993 | 14.381 | -7% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.12B | 195B | 1% |
Annual Yield % from dividends | 1.09 | 2.25 | 48% |
Returns for 1 year | -0.47 | 15.09 | -3% |
Returns for 3 years | -10.62 | 17.92 | -59% |
Returns for 5 years | -5.48 | 42.89 | -13% |
Returns for 10 years | -6.79 | 99.89 | -7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNCX | 57.83 | 0.59 | +1.03% |
Janus Henderson Global Life Sciences C | |||
FWRAX | 10.59 | 0.03 | +0.28% |
Fidelity Advisor Global Real Estate A | |||
MADAX | 28.49 | 0.06 | +0.21% |
Madison Dividend Income A | |||
DNLCX | 51.10 | -0.05 | -0.10% |
BNY Mellon Active MidCap C | |||
VRTGX | 403.07 | -1.55 | -0.38% |
Vanguard Russell 2000 Growth Index I |